Tag Archives: NDEA
-
-
Status of Valsartan Recall Claims to be Reviewed at Case Management Conference
-
Valsartan Bladder Cancer Lawsuit Filed Over Generic Drug Manufacturing Problems
-
Tainted Valsartan Led To Kidney Cancer, Tumor Removal Surgery, Lawsuit Claims
-
Generic Valsartan Lawsuit Blames Tainted Pills For Lung Cancer And Pancreatic Cancer Diagnoses
-
Class Action Lawsuit Alleges Valsartan Impurities Made Made Recalled Generics New, Unapproved Drugs
-
Valsartan Gastrointestinal Cancer Lawsuit Alleges Chemical Impurities Led to Diagnosis, Need for Bowel Resection Surgery
-
Valsartan Recalls “Tip Of the Iceberg” On Imported Drug Problems, Former FDA Inspector Tells NBC
-
Torrent’s Losartan Manufacturing Plant Had Numerous Issues, FDA Investigation Reveals
-
Leadership Structure Established for Valsartan Attorneys Involved in Federal Litigation